Draft for clinical review
Weight Management Treatment Information
There are several prescription medicines licensed for weight management in the UK.
The information below is provided to help patients understand treatments that may be considered following an individual clinical assessment.
Treatment suitability and prescribing decisions are determined by the prescribing clinician.
Educational only
This section does not confirm suitability or replace clinical advice.
No medicine prices
These draft pages are not shop or checkout pages.
Clinician decision
Prescribing depends on an individual assessment.
Mounjaro / tirzepatide
Active ingredient: tirzepatide
An injectable prescription medicine that may be considered for weight management following individual clinical assessment.
Read draft informationInformationWegovy Injection / semaglutide
Active ingredient: semaglutide
An injectable prescription medicine that may be considered for weight management after clinical assessment.
Read draft informationInformationWegovy Tablets / semaglutide
Active ingredient: semaglutide
An oral semaglutide treatment option that may be considered for weight management after clinical assessment where available and appropriate.
Read draft informationInformationOrlistat
Active ingredient: orlistat
An oral prescription medicine that may be considered for weight management after clinical assessment.
Read draft informationThere is no single treatment that is suitable for everyone. Your medical history, current health, previous treatment and other relevant factors will be considered by the prescribing clinician before any treatment is recommended.